BIOL 0170 Lecture Notes - Lecture 19: Kendall Square, Tissue Engineering, Venture Capital
7 Dec 2016
School
Department
Course
Professor
Document Summary
Trump administration - changes in policy regarding innovation of biotechnology: too early to tell, less funding for research, price controls that have had a very negative impact are less likely to happen. Have a chilling effect on money for the biotech industry. Policies regarding the ownership of intellectual property - ideal situation with respect to academic environments: 2011: laws that changed the patent system that had a negative effect on academia. New patent challenges that hedge fund managers are doing. Suing companies and shorting their stocks: not sure if they will continue to stand or not but they were, american invents act. Bad for biotech, pharmaceutical industry, small inventor. How do you know if an invention is ready for commercialization: from an academic perspective, depends on area you"re talking about. If something is in the medical area, when it"s ready to move from research to development. Enough proof of principle (animals) --> ready for commercialization.
